Hepatocellular Carcinoma — Trials

Hepatocellular Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

3,123 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 693
Recruiting: 411
Ph III recruiting: 39
Growth YoY: +0.6%
Industry share: 23%
Top sponsor: Sun Yat-sen University
Termination share: 34.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (356)

clinicaltrialsPublishedShowing 1,001–1,001 of 1,001 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00006332	Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate	completed	Phase 2	—	National Center for Research Resources (NCRR)NIH	1	Jun 24, 2005	clinicaltrials